0001467435-14-000001.txt : 20140616 0001467435-14-000001.hdr.sgml : 20140616 20140613181334 ACCESSION NUMBER: 0001467435-14-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140616 DATE AS OF CHANGE: 20140613 EFFECTIVENESS DATE: 20140616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Presidio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001467435 IRS NUMBER: 510572796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-195112 FILM NUMBER: 14911171 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 585 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-655-7560 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 585 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D/A 1 primary_doc.xml X0707 D/A LIVE 0001467435 Presidio Pharmaceuticals, Inc. 1700 OWENS STREET SUITE 585 SAN FRANCISCO CA CALIFORNIA 94158 415-655-7560 DELAWARE None None Corporation true H. Daniel Perez 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Director Leo Redmond 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Executive Officer Director Scott Lessing 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Director Nathaniel Brown 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Executive Officer Richard Colonno 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Executive Officer Leping Li 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Executive Officer Eric Ruby 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Executive Officer Omar Haffar 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Director Robert Williamson 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Director Pamela Vig 1700 Owens Street Suite 585 San Francisco CA CALIFORNIA 94158 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001467435-13-000001 2013-04-05 true true false 0 22500000 21827981 672019 Series D Preferred Stock; Common Stock issuable upon conversion false 16 0 0 1000000 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries false Presidio Pharmaceuticals, Inc. /s/ Leo Redmond Leo Redmond President 2014-06-13